HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brain-targeting delivery for RNAi neuroprotection against cerebral ischemia reperfusion injury.

Abstract
Nanoparticles (NPs) with modification of brain-targeting molecules have been extensively exploited for therapeutic gene delivery across the blood-brain barrier (BBB). As one of the effective RNA interference (RNAi) approaches, short hairpin RNA (shRNA) has been proved to be promising in the field of gene therapy. Apoptosis signal-regulating kinase 1 (Ask1) has been reported to be an important target for gene therapy against cerebral ischemia reperfusion injury. In this study, dendrigraft poly-l-lysine (DGL) was decorated by dermorphin (a μ-opiate receptor agonist) through PEG for efficient brain-targeting, then complexed with anti-Ask1 shRNA plasmid DNA, yielding the DGL-PEG-dermorphin/shRNA NPs. The DGL-PEG-dermorphin/shRNA NPs were characterized and estimated the brain-targeting ability. In vitro, increased cellular uptake and transfection efficiency were explored; in vivo, preferable accumulation and gene transfection in brain were showed in images. The DGL-PEG-dermorphin/shRNA NPs also revealed high efficiency of neuroprotection. As a result of RNAi, corresponding mRNA was distinctly degraded, expression of Ask1 protein was obviously suppressed, apoptotic cell death was apparently decreased and cerebral infarct area was significantly reduced. Above all, DGL-PEG-dermorphin/shRNA NPs were proved to be efficient and safe for brain-targeting RNAi neuroprotection against cerebral ischemia reperfusion injury.
AuthorsSai An, Yuyang Kuang, Teng Shen, Jianfeng Li, Haojun Ma, Yubo Guo, Xi He, Chen Jiang
JournalBiomaterials (Biomaterials) Vol. 34 Issue 35 Pg. 8949-59 (Nov 2013) ISSN: 1878-5905 [Electronic] Netherlands
PMID23968852 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • RNA, Small Interfering
  • Polylysine
  • Polyethylene Glycols
Topics
  • Animals
  • Blood-Brain Barrier (metabolism)
  • Brain (metabolism)
  • Cell Line, Tumor
  • Cerebral Infarction (prevention & control)
  • Endothelial Cells (cytology, metabolism)
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Humans
  • Male
  • Mice
  • Mice, Inbred ICR
  • Mice, Nude
  • Nanoparticles (administration & dosage, chemistry)
  • Plasmids
  • Polyethylene Glycols (chemistry)
  • Polylysine (chemistry)
  • RNA Interference (physiology)
  • RNA, Small Interfering (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (therapy)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: